Brain Connectivity and Corticospinal Excitability in Response to Moderate Hypoxia

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUniversite du Littoral Cote d'Opale

About this trial

Hypoxia, defined as a reduction in the availability of oxygen, induces significant physiological adaptations. While the deleterious effects of severe and chronic hypoxia are well documented, several studies indicate that moderate hypoxia - particularly when administered intermittently - may produce beneficial effects on cardiometabolic health (e.g., improved regulation of blood pressure and better glycaemic control). However, its impact on the dynamics of brain circuits in humans remains relatively underexplored. The present project aims to characterise the effects of continuous and intermittent moderate hypoxia on resting-state brain dynamics in healthy adults. To this end, simultaneous electroencephalography (EEG) and functional near-infrared spectroscopy (fNIRS) recordings will be conducted in order to extract functional and haemodynamic markers of brain activity. This project will contribute to a better understanding of the neurophysiological mechanisms associated with hypoxic conditioning and to the assessment of its potential application in innovative therapeutic approaches.

Eligibility criteria

Qualifiers

Male or female aged 18 to 65 years

Healthy right- or left-handed individuals with no self-reported neurological disorders or history of neurological conditions (e.g., epilepsy, stroke, brain or spinal surgery, or neurological diseases affecting motor or sensory function such as multiple sclerosis, or neurodegenerative diseases such as Parkinson's or Alzheimer's)

Individuals who have provided informed consent and have sufficient proficiency in French

Participants affiliated with, or beneficiaries of, a social security scheme

Disqualifiers

Body mass index (BMI) greater than 30 kg/m²

Diagnosed and untreated obstructive sleep apnoea syndrome

Inability to provide informed consent

History of cardiac (e.g., ischaemic heart disease, heart failure) and/or respiratory disorders (e.g., COPD, chronic respiratory insufficiency, persistent or uncontrolled asthma)

Trial design

Treatments tested in this trial

  • Moderate hypoxia
  • Normoxia
  • Transcranial Magnetic Stimulation

Treatment groups

36 Participants
are divided into 3 treatment groups